Maxmavil, Amlodipin Receive Korea New Drug Awards
Published: 2005-03-02 06:56:00
Updated: 2005-03-02 06:56:00
The Korea Drug Research Association (KDRA) selected Maxmavil by Yuyu Inc. and Amlodipin by Hanmi Pharmaceutical as the Korea New Drug Award recipients, where the award ceremony was held last week at the Seoul National University.
Maxmavil is a novel combination drug for treatment of osteoporos...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
